ArticleCurrent medicinal chemistry2025
LNX1-AS2 as a Key Prognostic and Immunotherapy Response Biomarker for Lung Adenocarcinoma.
Xiuxiu Wang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleCurrent medicinal chemistry2025
Xiuxiu Wang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.